Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers-Reference-Cited by-同舟云学术

Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers

Published:2018-08-06 Issue:3 Volume:21 Page:509-518
ISSN:1536-1632
Container-title:Molecular Imaging and Biology
language:en
Short-container-title:Mol Imaging Biol

Author:

Constantinescu Cristian C.^ORCID,Tresse Cedric,Zheng MingQiang,Gouasmat Alexandra,Carroll Vincent M,Mistico Laetitia,Alagille David,Sandiego Christine M.,Papin Caroline,Marek Kenneth,Seibyl John P.,Tamagnan Gilles D.,Barret Olivier

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11307-018-1260-5.pdf

Reference30 articles.

1. Bajjalieh SM, Scheller RH (1995) The biochemistry of neurotransmitter secretion. J Biol Chem 270:1971–1974

2. Bajjalieh SM, Peterson K, Linial M, Scheller RH (1993) Brain contains two forms of synaptic vesicle protein 2. Proc Natl Acad Sci U S A 90:2150–2154

3. Douaud M, Feve K, Pituello F, Gourichon D, Boitard S, Leguern E, Coquerelle G, Vieaud A, Batini C, Naquet R, Vignal A, Tixier-Boichard M, Pitel F (2011) Epilepsy caused by an abnormal alternative splicing with dosage effect of the SV2A gene in a chicken model. PLoS One 6:e26932

4. Kaminski RM, Matagne A, Leclercq K, Gillard M, Michel P, Kenda B, Talaga P, Klitgaard H (2008) SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology 54:715–720

5. Kaminski RM, Gillard M, Klitgaard H (2012) Targeting SV2A for discovery of antiepileptic drugs. In: Jasper’s basic mechanisms of the epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US)

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noninvasive quantification of [18F]SynVesT-1 binding using simplified reference tissue model 2;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-19

2. Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression;Neuropsychopharmacology;2024-07-22

3. Preclinical validation and kinetic modelling of the SV2A PET ligand [¹⁸F]UCB-J in mice;2024-07-16

4. A systematic review and meta-analysis of neuroimaging studies examining synaptic density in individuals with psychotic spectrum disorders;BMC Psychiatry;2024-06-19

5. SV2A PET imaging in human neurodegenerative diseases;Frontiers in Aging Neuroscience;2024-04-18